Jiangsu Jibeier Pharmaceutical Co Ltd
688566
Company Profile
Business description
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
Contact
High-tech Industrial Development Zone
Jiangsu Province
Zhenjiang212000
CHNT: +86 51188898101
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,327
Stocks News & Analysis
stocks
Nvidia: Collaboration with Intel might bring some goodwill with the US
We doubt the $5 billion is meaningful enough to force Nvidia to use Intel, either for core products or even for the chips in collaboration.
stocks
What now for Santos after takeover offer collapses?
Our Fair Value estimate once again reflects the stand-alone business and its growth potential.
stocks
Morningstar initiates coverage on small cap ASX REIT
Coverage of ASX listed REIT as investor interest in property continues to grow.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,102.10 | 11.70 | 0.13% |
| CAC 40 | 7,853.59 | 1.02 | -0.01% |
| DAX 40 | 23,639.41 | 35.12 | -0.15% |
| Dow JONES (US) | 46,315.27 | 172.85 | 0.37% |
| FTSE 100 | 9,216.67 | 11.44 | -0.12% |
| HKSE | 26,238.83 | 306.27 | -1.15% |
| NASDAQ | 22,631.48 | 160.75 | 0.72% |
| Nikkei 225 | 45,534.33 | 488.52 | 1.08% |
| NZX 50 Index | 13,141.54 | 90.12 | -0.68% |
| S&P 500 | 6,664.36 | 32.40 | 0.49% |
| S&P/ASX 200 | 8,810.90 | 11.40 | 0.13% |
| SSE Composite Index | 3,817.00 | 3.09 | -0.08% |